CNBC: Pfizer oral weight loss drug may be as effective as Ozempic injection by Novo Nordisk, study says


Pfizer’s recent phase 2 clinical study using their new oral weight loss drug showed promising results and can be comparable to that of Novo Nordisk’s Ozempic injections, which have showed prominent results in many obese and diabetic patients. The new pill works by triggering insulin release in the pancreas as a GLP-1R (Glucagon-like peptide 1 receptor) agonist. Click here to learn more about the study and here to read the article.

Comments are closed.

Skip to toolbar